192 Publications (Page 4 of 8)
2013
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer
Ellis, LeighKu, ShengYuRamakrishnan, SwathiLasorsa, ElenaAzabdaftari, GizzouGodoy, Alejandro and Pili, Roberto
Oncotarget, vol. 4, (no. 12), pp. 2236, 2013-12-31. | Journal Article
 
Dietary protein restriction inhibits tumor growth in human xenograft models.
Fontana, LuigiAdelaiye, Remi MRastelli, Antonella LMiles, Kiersten MCiamporcero, EricLongo, Valter DNguyen, HollyVessella, Robert and Pili, Roberto
Oncotarget, vol. 4, (no. 12), pp. 2451-61, 2013/Dec. | Journal Article
 
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer
Fontana, LuigiAdelaiye, Remi MRastelli, Antonella LMiles, Kiersten MarieCiamporcero, EricLongo, Valter DNguyen, HollyVessella, Robert and Pili, Roberto
Oncotarget, vol. 4, (no. 12), pp. 2461, 2013-12-31. | Journal Article
 
High-dose interleukin-2 therapy for metastatic renal cell carcinoma: A contemporary experience
Aboumohamed, Ahmed AYarlagadda, NaveenCreighton, TerranceMehedint, DianaAttwood, KristopherKauffman, EricGeorge, SabyKhushalani, Nikhil IPili, Roberto and Schwaab, Thomas
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. e15604, 2013-05-20. | Journal Article
 
Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
Ramakrishnan, Swathi and Pili, Roberto
Cancer journal (Sudbury, Mass.), vol. 19, (no. 4), pp. 333-340. | Journal Article
 
Histone modifications: implications in renal cell carcinoma
Ramakrishnan, SwathiRamakrishnan, SwathiEllis, LeighEllis, LeighPili, Roberto and Pili, Roberto
Epigenomics, vol. 5, (no. 4), pp. 462, 2013-August-01. | Journal Article
 
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.
Armstrong, Andrews JHäggman, MStadler, W MGingrich, J RAssikis, VPolikoff, JDamber, J EBelkoff, LNordle, ÖForsberg, GCarducci, M A and Pili, R
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 19, (no. 24), pp. 6891-901, 2013/Dec/15. | Journal Article
 
Major response to cyclophosphamide and prednisone in recurrent castration-resistant prostate cancer.
Batty, NicolasYarlagadda, Naveen and Pili, Roberto
Journal of the National Comprehensive Cancer Network : JNCCN, vol. 11, (no. 8), pp. 911-915, August 2013. | Journal Article
 
Tasquinimod: A Novel Angiogenesis Inhibitor–Development in Prostate Cancer
George, SabyGeorge, SabyPili, Roberto and Pili, Roberto
Current Oncology Reports, vol. 15, (no. 2), pp. 68, 20130400. | Journal Article
 
Understanding Avoidance, Refusal, and Abandonment of Chemotherapy Before and After Cystectomy for Bladder Cancer
Rehman, ShabnamRehman, ShabnamCrane, AliceCrane, AliceDin, RakeebaDin, RakeebaRaza, Syed JRaza, SyedShi, YiShi, YiWilding, Gregory AWilding, GregoryLevine, EllisLevine, Ellis GGeorge, SabyGeorge, SabyPili, RobertoPili, RobertoTrump, Donald LTrump, DonaldGuru, Khurshid and Guru, Khurshid A
Urology, vol. 82, (no. 6), pp. 1375, 2013. | Journal Article
 
Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model
Chatterjee, SubrotoChatterjee, SubrotoAlsaeedi, NezarAlsaeedi, NezarHou, JenniferHou, JenniferBandaru, Veera Venkata RatnamWu, LanWu, LanHalushka, Marc KHalushka, Marc KPili, RobertoPili, RobertoNdikuyeze, GeorgesNdikuyeze, GeorgesHaughey, Norman J and Haughey, Norman J
PloS one, vol. 8, (no. 5), pp. e63726, 2013-00-00. | Journal Article
2012
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate
Bruce, Justine YBruce, JustineBruce, JustineEickhoff, JensEickhoff, JensEickhoff, JensPili, RobertoPili, RobertoPili, RobertoLogan, TheodoreLogan, TheodoreLogan, TheodoreCarducci, MichaelCarducci, MichaelCarducci, MichaelArnott, JamieArnott, JamieArnott, JamieTreston, AnthonyTreston, AnthonyTreston, AnthonyWilding, GeorgeWilding, GeorgeWilding, GeorgeLiu, GlennLiu, Glenn and Liu, Glenn
Investigational New Drugs, vol. 30, (no. 2), pp. 802, 20120400. | Journal Article
 
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
Keizman, DanielKeizman, DanielIsh-Shalom, MayaIsh-Shalom, MayaPili, RobertoPili, RobertoHammers, HansHammers, HansEisenberger, Mario AEisenberger, MarioSinibaldi, VictoriaSinibaldi, VictoriaBoursi, BenBoursi, BenMaimon, NatalieMaimon, NatalieGottfried, MayaGottfried, MayaHayat, HenryHayat, HenryPeer, AvivitPeer, AvivitKovel, SvetlanaKovel, SvetlanaSella, AvishaySella, AvishayBerger, RaananBerger, RaananCarducci, Michael and Carducci, Michael A
European Journal of Cancer, vol. 48, (no. 7), pp. 1037, 2012. | Journal Article
 
Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
Shen, LiShen, LiPili, Roberto and Pili, Roberto
OncoImmunology, vol. 1, (no. 6), pp. 950, 9/1/2012. | Journal Article
 
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
Shen, LiShen, LiShen, LiCiesielski, MichaelCiesielski, MichaelCiesielski, Michael JRamakrishnan, SwathiRamakrishnan, SwathiRamakrishnan, SwathiMiles, Kiersten MMiles, Kiersten MMiles, Kiersten MEllis, LeighEllis, LeighEllis, LeighSotomayor, PaulaSotomayor, PaulaSotomayor, PaulaShrikant, ProtulShrikant, ProtulShrikant, ProtulFenstermaker, RobertFenstermaker, RobertFenstermaker, Robert APili, RobertoPili, Roberto and Pili, Roberto
PloS one, vol. 7, (no. 1), pp. e30815, 2012-00-00. | Journal Article
 
Contrasting effects of sunitinib within in vivo models of metastasis.
Welti, Jonathan CPowles, ThomasFoo, ShaneGourlaouen, MorganePreece, NatashaFoster, JulieFrentzas, SophiaBird, DemelzaSharpe, Kevinvan Weverwijk, AntoinetteRobertson, DavidSoffe, JulieErler, Janine TPili, RobertoSpringer, Caroline JMather, Stephen J and Reynolds, Andrew R
Angiogenesis, vol. 15, (no. 4), pp. 623-41, 2012/Dec. | Journal Article
 
Development of a castrate resistant transplant tumor model of prostate cancer
Ellis, LeighEllis, LeighLehet, KristinLehet, KristinRamakrishnan, SwathiRamakrishnan, SwathiAdelaiye, RemiAdelaiye, RemiPili, Roberto and Pili, Roberto
The Prostate, vol. 72, (no. 6), pp. 591, 1 May 2012. | Journal Article
 
Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks
Ebos, John M LEbos, John MPili, Roberto and Pili, Roberto
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 14), pp. 3721, 2012-Jul-15. | Journal Article
 
Modulation of Chemotherapeutic Efficacy by Vascular Disrupting Agents: Optimizing the Sequence and Schedule
Wang, Eunice SWang, Eunice SPili, RobertoPili, RobertoSeshadri, Mukund and Seshadri, Mukund
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 7), pp. 761, 2012-Mar-01. | Journal Article
 
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells
Minelli, RosalbaMinelli, RosalbaCavalli, RobertaCavalli, RobertaEllis, LeighEllis, LeighPettazzoni, PiergiorgioPettazzoni, PiergiorgioTrotta, FrancescoTrotta, FrancescoCiamporcero, EricCiamporcero, EricBarrera, GiuseppinaBarrera, GiuseppinaFantozzi, RobertoFantozzi, RobertoDianzani, ChiaraDianzani, ChiaraPili, Roberto and Pili, Roberto
European Journal of Pharmaceutical Sciences, vol. 47, (no. 4), pp. 694, 2012-11-20. | Journal Article
 
Pretreatment Neutrophil‐to‐Lymphocyte Ratio in Metastatic Castration‐Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
Keizman, DanielKeizman, DanielGottfried, MayaGottfried, MayaIsh‐Shalom, MayaIsh-Shalom, MayaMaimon, NatalieMaimon, NataliePeer, AvivitPeer, AvivitNeumann, AvivitNeumann, AvivitRosenbaum, EliRosenbaum, EliKovel, SvetlanaKovel, SvetlanaPili, RobertoPili, RobertoSinibaldi, VictoriaSinibaldi, VictoriaCarducci, Michael ACarducci, Michael AHammers, HansHammers, HansEisenberger, Mario AEisenberger, Mario ASella, Avishay and Sella, Avishay
The Oncologist, vol. 17, (no. 12), pp. 1514, December 2012. | Journal Article
 
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition
Chintala, SreenivasuluChintala, SreenivasuluNajrana, TanbirNajrana, TanbirToth, KarolyToth, KarolyCao, ShousongCao, ShousongDurrani, Farukh ADurrani, Farukh APili, RobertoPili, RobertoRustum, Youcef M and Rustum, Youcef M
BMC cancer, vol. 12, (no. 1), pp. 293, 2012-Jul-17. | Journal Article
 
Testicular Cancer
Grivas, PMotzer, Robert JMotzer, RJMotzer, Robert JAgarwal, NeerajAgarwal, NAgarwal, NeerajSmith, DcBeard, CBeard, ClairBeard, ClairBhayani, SamBhayani, SBhayani, SamBolger, Graeme BBolger, GBBolger, Graeme BBuyyounouski, Mark KBuyyounouski, MKBuyyounouski, Mark KCarducci, Michael ACarducci, Michael ACarducci, MAChang, SSChang, Sam SChang, Sam SChoueiri, Toni KChoueiri, Toni KChoueiri, TKGupta, SGupta, ShilpaGupta, ShilpaHancock, SLHancock, Steven LHancock, Steven LHudes, GRHudes, Gary RHudes, Gary RJonasch, EJonasch, EricJonasch, EricKuzel, TMKuzel, Timothy MKuzel, Timothy MLau, ClaytonLau, ClaytonLau, CLevine, EGLevine, Ellis GLevine, Ellis GLin, DWLin, Daniel WLin, Daniel WMargolin, Kim AMargolin, KAMargolin, Kim AMichaelson, M DrorMichaelson, MDMichaelson, M DrorOlencki, ThomasOlencki, TOlencki, ThomasPili, RobertoPili, RobertoPili, RRatliff, TWRatliff, Thomas WRatliff, Thomas WRedman, Bruce GRedman, Bruce GRedman, BGRobertson, Cary NRobertson, CNRobertson, Cary NRyan, CJRyan, Charles JRyan, Charles JSheinfeld, JoelSheinfeld, JSheinfeld, JoelWang, JueWang, JWang, JueWilder, Richard BWilder, RB and Wilder, Richard B
Journal of the National Comprehensive Cancer Network : JNCCN, vol. 10, (no. 4), pp. 535, 2012-Apr. | Journal Article
 
Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma
Ellis, LeighEllis, LeighShah, PreetiShah, PreetiHammers, HansHammers, HansLehet, KristinLehet, KristinSotomayor, PaulaSotomayor, PaulaAzabdaftari, GissouAzabdaftari, GissouSeshadri, MukundSeshadri, MukundPili, Roberto and Pili, Roberto
Molecular cancer therapeutics, vol. 11, (no. 2), pp. 392, 2012-Feb. | Journal Article
2011
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
Keizman, DanielKeizman, DanielHuang, PengHuang, PengEisenberger, Mario AEisenberger, MarioPili, RobertoPili, RobertoKim, Jenny JKim, JennyAntonarakis, Emmanuel SAntonarakis, EmmanuelHammers, HansHammers, HansCarducci, Michael A and Carducci, Michael
European Journal of Cancer, vol. 47, (no. 13), pp. 1961, 2011. | Journal Article